Advertisement
News
Advertisement

Foundation Medicine continues partnership streak

Mon, 11/12/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Just as it did in 2011, Foundation Medicine has inked its fourth partnership this year. The Cambridge cancer diagnostics company’s latest partnership agreement is with AstraZeneca (AZN:LN), a biopharmaceutical company headquartered in London.

Together, the companies are working to identify alterations in cancer-related tumor genes that could potentially predict a person’s response or resistance to specific medicine.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading